Last reviewed · How we verify

NCT05166395

Laser Treated Scars and Optical Coherence Tomography (OCT)

Withdrawn NA Last updated 20 February 2024
What this trial tests

NA trial testing Er:YAG laser in Scar. Withdrawn.

Timeline
1 May 2024
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Start date1 May 2024
Primary completion1 December 2025
Estimated completion1 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, any sex, with Scar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to learn about the effects of the 2940 nm Erbium: Yttrium-Aluminum-Garnet (Er:YAG) laser on treating surgical scar using optical coherence tomography, a medical imaging device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Er:YAG laser

Trials testing the same drug.

Other recruiting trials for Scar

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05166395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing